Article Details

Roche's Polivy meets primary goal in Phase III lymphoma trial

Retrieved on: 2021-08-10 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

Roche's Polivy meets primary goal in Phase III lymphoma trial. View article details on hiswai:

Excerpt

Roche has reported that Polivy (polatuzumab vedotin) plus chemotherapy regimen met the primary goal of Phase III POLARIX clinical trial for treatment ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up